Tillie Mae Mawdsley is just nine years old, and is not expected to live to see her teenage years.
When she was just a toddler, Tillie was diagnosed with a rare genetic condition called Sanfilippo, which causes the progressive breakdown of the central nervous system.
The life-limiting illness means Tillie will lose the ability to walk, talk and eat. The condition is likened to a childhood form of dementia.
"It's memory loss, the disease attacks the brain," Tillie's mum, 36-year-old Michala Mawdsley told The Sun of her daughter's condition.
"It's horrible, it really is like a childhood dementia."
For the last six years, Tillie has been a part of a clinical trial offered to just six children in the UK by an American pharmaceutical company. The enzyme replacement therapy involved Tillie and her family making a 640km round trip from their home in Hertforshire to Manchester Children's Hospital every four weeks.
Now, the drug trial has been stopped without warning, stating that patient's weren't improving.
Tillie's parents believe she has now been handed "a life sentence".
"We feel like the rug has been pulled from beneath us... It's difficult to accept there's nothing we can do for her now," mum Michala said.
"Tillie’s treatment gave her a quality of life. The trial was making her better and I believe that drug was working."
Michala and her 40-year-old husband Paul believe the drug had stopped Tillie Mae's symptoms from worsening.
Top Comments
So very sad... this awful disease is what my beautiful daughter had. Tragically she passed away aged 14 in 2009 and looked exactly like Tillie. My heart goes out to the family... I know what they're going through💖